FIELD: chemistry.
SUBSTANCE: in formulas (I) and (Ia) . A is 1-cyclopentene-1,2-diyl; Z1 and Z2 are O; E is phenyl substituted with 1-4 substituting groups selected from halogen, Y is phenyl substituted with 1-2 substituting groups selected from halogen, C1-C6alcoxy, halogen C1-C6alcoxy; the meaning of other radicals are indicated in the formula of the invention. The invention refers also to the pharmaceutical composition including the compound of the invention, to the application of the said compound at preparation of the medicinal agent and to the application for DHODH inhibition.
EFFECT: compound of the present invention can find application as medicinal agent inhibiting dehydroorotate dehydrogenase.
9 cl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
AROMATIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATING AND ANTIPROLIFERATIVE AGENTS | 2003 |
|
RU2386625C2 |
NEW COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATING, AND ANTI-PROLIFERATIVE AGENTS | 2002 |
|
RU2309946C2 |
COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
COMPOUNDS AS INHIBITORS OF VLA-4 | 2000 |
|
RU2264386C2 |
S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
ANTIVIRAL COMPOUDS | 2006 |
|
RU2441869C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
Authors
Dates
2009-09-20—Published
2003-12-17—Filed